Annals of Nuclear Cardiology
Online ISSN : 2424-1741
Print ISSN : 2189-3926
ISSN-L : 2189-3926
Which PET Flow Tracer Is the Best for MBF Quantification?
PET/CT with 13N-ammonia
Characteristics and Utility in Coronary Artery Disease
Isabel Carvajal-JuarezAndrea Monroy-GonzalezNilda Espinola-ZavaletaAloha Meave-GonzalezErick Alexanderson-Rosas
Author information

2019 Volume 5 Issue 1 Pages 63-68


Currently, 13N-ammonia and Rubidium-82 (82Rb) are the only FDA-approved myocardial perfusion positron emission tomography (PET) tracers for myocardial perfusion imaging in the evaluation of suspected or known coronary artery disease (CAD), quantification of left ventricular volumes and systolic function and quantification of global and regional myocardial blood flow (MBF) and myocardial flow reserve (MFR). Nevertheless, there are physical, chemical and molecular differences between them. The ideal perfusion tracer would include 100% extraction from blood to tissue, and 100% retention, resulting in a linear relationship between MBF and the measured tracer activity over a wide range. However, both 13N-ammonia and 82Rb have limited characteristics. In this review, we aim to analyze 13N-ammonia in detail, and its differences with other radiotracers for the assessment of myocardial perfusion.

Information related to the author
© The Japanese Society of Nuclear Cardiology 2019
Previous article Next article